Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • Please provide declaration of generative Artificial intelligence (AI) and AI-assisted technologies in the writing process. Please mention NAME TOOL/SERVICE in order to (REASON- give details in the manuscript)

Author Guidelines


Authors should submit the manuscript typed in MS Word. Manuscripts should be written in English in British or American format and in past tense. Sentences should not start with a number or figure. Illustrations or photographs should be sent in duplicate. Components of manuscript should be in the following sequence: a title page (containing names of authors, their postal and Email addresses, fax and phone numbers, including mobile phone number of the corresponding author), abstract, key words, text, references, tables (each table, complete with title and footnotes) and legends for illustrations and photographs. Each component should begin on a new page. Sub-headings should not be used in any section of the script except in the abstract. Acknowledgements are only printed for the financing of a study or for acknowledging a previous linked work. The manuscript should be typed in double spacing as a single column on A4 (8-1/2" x 11" or 21.5 cm x 28.0 cm), white bond paper with one inch (2.5 cm) margin on one side.

1A. Material for publication:

The material submitted for publication may be in the form of an Original research (Randomized controlled trial - RCT, Meta-analysis of RCT, Quasi experimental study, Case Control study, Cohort study, Observational Study with statistical support etc), a Review Article, an Evidence based report, a Case Report, New techniques (can be reported as changes made by the authors to an existing technique or development of a new technique or instrument and experience with it), or Clinical Practice Article. Any study ending more than three years prior to date of submission will not be accepted. Multiple end publications derived from a single research project known as 'salami slices' are also not acceptable .

The Original Article should be of 2000-2500 words excluding abstract and references. It should contain a structured abstract of about 250 words. Three to 10 keywords should be given for an original article as per MeSH (Medical Subject Headings). There should be no more than three tables or illustrations. The paper should have 20 to 25 references, which should include local as well as international references. Most of the references should be from last five years from the date of submission.

Review Article should consist of critical overview/analysis of a specific topic providing background and the recent development with reference to original literature. It should incorporate author's original work on the same subject. The length of the review article should be of 2500 to 3000 words with a maximum of 60 references. It should have non-structured abstract of 150 words with minimum 3 key words. An author can write a review article only if he/she has written a minimum of three original research articles and some case reports on the same topic.

Clinical Case Reports must be of academic and educational value and provide relevance of the disease being reported as unusual. The word count of case report should be 800 words with a minimum of 3 key words. It should have a non-structured abstract of about 100 - 150 words, maximum of 5 - 6 references and not more than 2 figures.

Clinical Practice Article is a category under which all simple observational case series are included. It should have 1500 - 1600 words with 15 to 20 references. The rest of the format should be that of an original article.

Evidence based reports must have at least 10 cases and word count of 1000 - 1200 words with 10 - 12 references and not more than 2 tables or illustrations. It should contain a non-structured abstract of about 150 words.

1B. Tables and illustrations:

Tables should be simple, and should supplement rather than duplicate information in the text; tables repeating information will be omitted. Each table should have a title and be typed in double space without horizontal and vertical lines on an 8-1/2" x 11" (21.5 x 28.0 centimeters) paper. Tables should be numbered consecutively with Roman numerals in the order they are mentioned in the text. Page number should be in the upper right corner. If abbreviations are used, they should be explained in footnotes. When graphs, scatter grams or histograms are submitted, the numerical data on which they are based should be supplied.

1C. Measurement Units:

A duly filled-in author's certification proforma is mandatory for publication (Download ACP Form). The duly signed ACP must be returned to the journal's office as soon as possible. The sequence/ order of the authors on ACP once submitted shall not be changed at any stage. Delay in submitting the ACP will result in delay in the processing and publication of the manuscript.

1D. Figures and photographs:

Photographs, X-rays, CT scans, MRI and photomicrographs should be sent in digital format with a minimum resolution of 3.2 mega pixels in JPEG compression. Photographs must be sharply focused. Most photographs taken with a mobile phone camera do not fulfill the necessary requirements and, therefore, not acceptable for printing. The background of photographs must be neutral and preferably white. The photographs submitted must be those originally taken as such by a camera without manipulating them digitally. The hard copy of the photographs must be unmounted, glossy prints, 5" x 7" (12.7 x 17.3 centimeters) in size. The author must identify the top of the figure. These figures and photographs must be cited in the text in consecutive order. Legends for photomicrographs should indicate the magnification, internal scale and the method of staining. Photographs of published articles will not be returned. If photographs of patients are used, either they should NOT be identifiable or the photographs should be accompanied by written permission to use them .

1E. Abbreviations:

Except for units of measurement, the first time an abbreviation appears, it should be preceded by the words for which it stands.

1F. References:

References should be cited in the 'Vancouver style'. References should be numbered in the order in which they are cited in the text. For details authors are directed to visit the 'ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals' available at


2A. Abstract:

Abstract of all articles (except Short Communications and Editorials) should be in structured format with the following subheadings: i. Objective. ii. Methodology. iii.  Results. vi. Conclusion. v. Keywords.  The total word count of abstract should be about 250 words. A minimum of 3 Key words as per MeSH (Medical Subject Headings)should be written at the end of abstract. A non-structured abstract should be written as case specific statement with a minimum of three key words.

2B. Introduction:

This section should include the purpose of the article after giving brief literature review strictly related to objective of the study. Only strictly pertinent references should be cited preferably not more than 10 references in this segment. Data, methodology or conclusion from the work being reported should not be presented in this section. It should end with a statement of the study objective.

2C. Methodology:

Study design and sampling methods should be given. Obsolete terms such as retrospective studies should not be used. The selection of the observational or experimental subjects (patients or experimental animals, including controls) should be described clearly. The methods and the apparatus used should be identified (with the manufacturer's name and address in parentheses), and procedures be described in sufficient detail to allow other workers to reproduce the results. References to established methods should be given, including statistical methods. References and brief descriptions for methods that have been published but are not well-known should be provided; only new or substantially modified methods should be described in detail, giving reasons for using them, and evaluating their limitations. All drugs and chemicals used should be identified precisely, including generic name (s), dose(s), and route(s) of administration. For statistical analysis, the specific test used should be named. SPSS output sheet must be attached with manuscript to clarify results (p-values). Exact p-values and 95% confidence interval (CI) limits must be mentioned instead of only stating greater or less than level of significance. All percentages must be accompanied with actual numbers.

2D. Results:

These should be presented in a logical sequence in the text, tables, and illustrations. All the data in the tables or illustrations should not be repeated in the text; only important observations should be emphasized or summarized.

2E. Discussion:

This section should include author's comment on the results, supported with contemporary references, including arguments and analysis of identical work done by other workers. Study limitations should also be mentioned.

2F. Conclusion:
A conclusion should highlight new aspects arising from the study and should be in accordance with the objectives. No recommendations are needed.


All interventional studies submitted for publication should carry Institutional Ethical & Technical Review Committee or Boards' approval letter from the involved institute(s). Manuscripts that include tables, illustrations or photographs, which have already been published, should be accompanied with a letter of permission for re-publication from author(s) as well as the editor of the journal where it was previously published. Written permission to reproduce photographs of patients, whose identity is not disguised, should be sent with the manuscript; otherwise the eyes will be blackened out. If a medicine is used, generic name should be used. The commercial name may, however, be mentioned only within brackets, only if necessary. In case of medicine or device or any material indicated in text, a declaration by author(s) should be submitted that no monetary benefit has been taken from manufacturer/importer of that product by any author. In case of experimental interventions, permission from ethical committee of the hospital should be taken beforehand. Any other conflict of interest must be disclosed.


Authors should disclose any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, a disclosure statement will appear with the article. Journal expects that authors of such articles will not have any significant financial interest in a company (or its competitor) that makes a product discussed in the article.


Credit for authorship requires substantial contributions to (a) the conception and design or analysis and interpretation of the data, (b) the drafting of the article or critical revision for important intellectual content, critical appraisal of findings with literature search and actual write up of manuscript, (c) final approval of the version to be published. Each author must sign a statement attesting that he or she fulfills the authorship criteria. Mere supervision, collection of data, statistical analysis and language correction do not grant authorship rights. Only six authors are allowed in a single institution study. In a multi institution and international collaboration research Editorial Board shall guide on individual case basis. Ideally all authors should belong to same department of an institute, except for multi-centre and multi-specialty studies.


Three copies of the journal will be sent to the corresponding author.


All the articles published in the journal will be licensed by CC-By 4.0.  We accept only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in this journal. The Editorial Board will make every effort to ensure the accuracy and authenticity of material printed in the journal. However, conclusions and statements expressed are views of the authors and do not necessarily reflect the opinions of the Editorial Board.


We observe/follow the ICMJE, PMDC and HEC guidelines/criteria for all types of plagiarism. The same can be accessed at, www.pmdc and It is the authors' responsibility to apprise themselves of plagiarism in any form including paraphrasing and self-plagiarism. Manuscripts submitted to us can be sent to HEC, other medical journal editors and international agencies for authentication of originality. The disciplinary committee comprising of editors and the chief editor will deal with cases of plagiarism.

Original Articles

This Section will contain the peer-reviewed original articles that will be available as Open Access.

Review Articles

This section will contain peer-reviewed review articles that will be available as open access as per journal's policy.

Case Reports/Case Series

This section will contain the published Case reports/Case Series.

Students' Section

This section will contain peer-reviewed student articles of all categories including original articles, review articles, in-silico studies, KAP studies etc.


This section will contain articles that contain some new hypothesis, theory, innovative technique etc.

Privacy Statement


Your privacy is important to MedERA-Journal of CMH LMC and IOD (referred to as MedERA hereafter).  This privacy statement provides information about the personal information that MedERA collects and the ways in which MedERA uses that personal information.
Personal information collection
MedERA may collect and use personal information that is necessary for the processing and publication of manuscripts submitted to us. This information may include names, affiliation and contact details; including postal address, emails, phone numbers and fax numbers.
Using personal information
Any personal information received by MedERA will only be used to process and publish your manuscript. 
  • administer this website;
  • personalize the website for you;
  • enable your access to and use of the website services;
  • process your manuscript;
  • publish your manuscript;
  • send to you communication about your manuscript
  • send to you statements and invoices;
  • collect payments from you; and
  • send you marketing communications.
Where MedERA discloses your personal information to its agents or sub-contractors for these purposes, the agent or sub-contractor in question will be obligated to use that personal information in accordance with the terms of this privacy statement. 
In addition to the disclosures reasonably necessary for the purposes identified elsewhere above, MedERA may disclose your personal information to the extent that it is required to do so by law, in connection with any legal proceedings or prospective legal proceedings, and in order to establish, exercise or defend its legal rights.
Securing your data
MedERA will take reasonable technical and organisational precautions to prevent the loss, misuse or alteration of your personal information. 
Cross-border data transfers
Information that MedERA collects may be stored and processed in and transferred between any of the countries in which MedERA operates to enable the use of the information in accordance with this privacy policy.
In addition, personal information that you submit for publication on the website will be published on the internet and may be available around the world.
You agree to such cross-border transfers of personal information.
Updating this statement
MedERA may update this privacy policy by posting a new version on this website.  
You should check this page occasionally to ensure you are familiar with any changes.  
Other websites
This website contains links to other websites.  
MedERA is not responsible for the privacy policies or practices of any third party.
Contact MedERA
If you have any questions about this privacy policy or MedERA treatment of your personal information, please send an email to